Displaying 1–25 of 284 results for Contract Service

Sort By Relevance Sort By Date
1 2 3 4 5 ...12

Solid Dose: Under-hyped but not under-represented

(Article)

The buzz may be around biologics, but the oral solid dose sector is still going strong

Pharma finds balance

(Article)

Despite negative public opinions and heavy demands, survey respondents indicate rising satisfaction and pride in their work

Product Focus: Digital Integration

(Article)

New business management solutions offer end-to-end manufacturing connections

Tech Transfer Communications

(Article)

Supply Chain: Transitioning from “forming and storming” to the desired “norming and performing” stages of project execution.

Pharma's Damaged Reputation

(Article)

Can the industry fix its image problem?

CMOs on Fire

(Article)

Four contract manufacturers who are redefining what it means to outsource

At the Forefront of ADC Manufacturing

(Article)

ADC BIO’s innovative technology is helping to usher in oncology’s new age of therapeutic agents

China's Biopharma Growth: Can it Continue?

(Article)

A new study shows a projected doubling of sales volume by 2021, as China strives to catch up with the global market

Biopharma Market: An Inside Look

(Article)

Survey results reveal how slow-motion trends are driving biopharma growth.

Dealing with Pharma's Digital Demons

(Article)

To advance, the pharma industry must confront its digital transformation fears head-on

API Sourcing: Your Questions Answered

(Article)

Sourcing high quality APIs in a cost and time efficient manner requires a detailed understanding of manufacturing regulations and global supply chains

Vendor Selection and Management From a Small Pharma Perspective

(Article)

Selecting the right vendor is critical for young companies. Here are six essential steps for making sure your company makes the right choice.

Supply Chain Strategies for New Therapies

(Article)

John Lunger, VP Manufacturing and Supply Chain Development, Adaptimmune on how autologous engineered T-cell therapies challenge traditional late stage and commercial pharma supply chains practices

The ‘Blueprint’ to Control Drug Prices: A Quick Guide for Manufacturers

(Article)

With regulatory measures related to drug prices and rebates supported by both sides of Congress, manufacturers should be prepared for new challenges.

Atrium Innovations Modernizes Quality Management

(Article)

Atrium improves audits and complaints, change control, and product release processes with immediate access to information and operational visibility

The Evolution of Quality

(Article)

Why good quality doesn't have to mean higher costs — in fact, it often means lower recall and warranty costs.

3 Signs Employee Turnover is Impacting Your Operational Efficiency

(Article)

Signs that CRO turnover is impacting your productivity, speed to market and bottom line.

Improving Digital Quality in the Pharmaceutical Industry

(Article)

Technology is helping to de-mystify the digital landscape and drive quality throughout the product life cycle.

3 Reasons Why the Pharma Supply Chain is Ripe for Digital Transformation

(Article)

Why the Pharma Supply Chain is Ripe for Digital Transformation

Biopharma CMO Consolidation: Opportunity or Obstacle?

(Article)

Why M&A may dominate the 2018 biopharma contract manufacturing landscape and the future may depend on the industry’s response to consolidation.

Contract Manufacturing & Development's Big Pharma Ascendency

(Article)

Contract Manufacturing & Development's Big Pharma Ascendency

Cutting-Edge Flexibility

(Article)

CDMOs perfect the art of survival in today’s multi-product world

EU FMD: The One-Year Countdown

(Article)

Companies that manufacture, sell or dispense drugs in the European Union have until February 9, 2019 to comply – where does the industry stand?

Downstream Gears Up

(Article)

How modern biopharma is cautiously melding new downstream technology into their processes.

CDMO Industry Thrives Amid Consolidation

(Article)

The underlying drivers for CDMO Industry developments and what they mean for the pharma industry as a whole

Sort By Relevance Sort By Date
1 2 3 4 5 ...12